DONATE NOW:Urgent Call for Healthy Donors as Blood Supply Drops to Dangerously Low LevelsSchedule Appointment

Ventures and Technology Development (VTD) Overview

New York Blood Center Enterprises’ Office of Ventures and Technology Development (VTD) is the place for prospective industry partners and LFKRI researchers to access and submit innovative ideas and technologies. We are your gateway to technology licenses, sponsored research, collaborations and venture creations across the entire NYBC Enterprise. VTD leverages the NYBC donor pool of hundreds of thousands of healthy individuals for cellular collections recruitment. There is no other blood center with as diverse a donor population as NYBC.

We look forward to working with you to bring important therapies and diagnostics to patients in a wide range of therapeutic areas, including but not limited to: 

  • Non-malignant hematology

  • Infectious diseases, including COVID-19

  • Cellular therapies

  • Transfusion medicine

  • Apheresis Medicine

  • And much more

Connect with Us

Our experienced team, led by Executive Vice President and Chief Financial and Business Officer, Jay Mohr, has deep expertise in basic research, business development, M&A and complex operations and integration.

CONTACT